<DOC>
	<DOC>NCT00821899</DOC>
	<brief_summary>This project evaluates the effectiveness of the administration of autologous bone marrow blood in patients with brittle type 1 diabetes mellitus to restore insulin secretion. After mobilization of hematopoietic progenitors (G-CSF) during 3 days, 50 to 90 mL of bone marrow blood will be obtained by multifunction in the posterior iliac crest. The material obtained will be implanted into the pancreas through the magna pancreatic artery after femoral catheterization.</brief_summary>
	<brief_title>Bone Marrow Autotransplantation in Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 1</mesh_term>
	<criteria>diabetes type 1 patients 18 to 50 years of age more than 5 years of evolution of the disease brittle diabetes (HbA1c &gt; 8.5 % with intensified treatment or severe hypoglycemia episodes history of cancer hematologic alterations infectious disease positivity (HIV, HCV etc.) diabetic nephropathy cardiac failure liver disease autoimmune systemic disease allergy to iodine contrast or anesthesia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>diabetes type 1</keyword>
	<keyword>bone marrow transplantation</keyword>
</DOC>